Serum-Free Cell Freezing Media: Benefits and Uses

A freezing medium should do more than help cells survive the thaw. For many primary-cell and cell-banking workflows, the real question is whether the recovered cells remain suitable for the next experiment – whether that means attachment, expansion, phenotype analysis, or another downstream assay. Serum-free cell freezing mediaremove serum from the cryopreservation formulation, which can […]
Cryopreservation Medium Selection for Primary Cells

For primary cells, the bestcryopreservation mediumis not simply the formulation with the longest feature list. It is the one that preserves the biological property you actually need after thawing. A medium can appear acceptable by viability alone yet be a poor fit if the cells recover slowly, lose a key surface marker, change morphology, or […]
How Animal PBMCs Support Translational Immunology

Translational immunology depends on experimental systems that can connect mechanistic findings with the biology of preclinical models. Animal peripheral blood mononuclear cells (PBMCs) are particularly useful in this role because they provide direct access to circulating mononuclear leukocytes while preserving the species and strain context of the in vivo model. For researchers comparing immune responses across discovery, […]
Animal Immune Cells: What Researchers Need to Know

Animal immune cells are widely used to connect mechanistic immunology with preclinical and translational research. The challenge is rarely simply obtaining “immune cells.” Researchers need the right biological source, species or strain, cell composition, post-thaw quality, and product format for the question being asked. A PBMC preparation, a bone marrow mononuclear cell preparation, and a […]
Primary Hepatocytes for ADME Studies: A Practical Guide

Primary hepatocytes for ADME studiesare presented in the MileCell product brochure as in vitro tools for drug development, hepatic metabolism, uptake, transport, hepatotoxicity, and hepatobiliary research. The brochure describes two main product formats – suspension hepatocytes and plateable hepatocytes – along with metabolism, induction, transporter, 3D spheroid, and ASGPR qualification options. Choosing a format begins […]
Suspension Hepatocytes in Drug Metabolism Testing

Suspension hepatocytesare presented in the MileCell product brochure as an in vitro model for drug metabolism and uptake studies. For research teams comparing compounds, species, strains, or cell lots, the central questions are practical: does the selected lot retain measurable metabolic activity after thawing, is the relevant Phase I or Phase II pathway characterized, and […]
Why 100 nm Nanomagnetic Beads Preserve Cell Viability and Function During Immune Cell Isolation

Magnetic bead separationis one of the most widely used methods for isolating immune cells in immunology and immuno-oncology research. But not all magnetic beads are equal. Beyond how pure the isolated population is, a factor that often decides whether an experiment succeeds is what the beads do to the cells: whether they preserve viability, leave […]
How to Isolate High-Purity CD8+ T Cells for Immuno-Oncology Research

CD8+ cytotoxic T cellsare central players in immuno-oncology. They recognize and kill tumor cells, drive responses to checkpoint inhibitors, and are the engineered effector cells behind many CAR-T and TCR-T therapies. Studying or manufacturing with these cells starts with one practical step: isolating them at high purity from a mixed population such as peripheral blood […]
High-Density CAR-T Cryopreservation: How to Maintain Viability and Potency at 2.5 × 10^7 Cells/mL

As CAR-T and other cell therapies scale from early studies toward routine manufacturing, how cells are frozen becomes as important as how they are made. One decision has outsized impact on logistics and cost: the cell density at which the product is cryopreserved. Freezing at high concentration, for example 2.5 x 10^7 cells/mL rather than […]
Why Chemically Defined Cell Freezing Media Preserve CAR-T Viability, Recovery, and CAR Expression After Thaw

Cryopreservation is a decisive step in CAR-T and other cell therapy workflows. Between manufacturing, release testing, shipping, and clinical administration, engineered cells are frozen and thawed at least once, and every freeze-thaw cycle is an opportunity to lose viability, cell number, and, critically, the engineered function that makes the product therapeutic. For CAR-T cells, that […]